SEC Comment Letter for Theriva Biologics, Inc. (TOVX) (CIK 0000894158) (TOVX) — May 7, 2008

Theriva Biologics, Inc. (TOVX) (CIK 0000894158)
Date: May 7, 2008 · CIK: 0000894158 · Accession: 0000000000-08-023576

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 001-12584

Date

April 29, 2008

Author

Jeffrey Riedler

Form

UPLOAD

Company

Theriva Biologics, Inc. (TOVX) (CIK 0000894158)

Letter

Mail Stop 6010 April 29, 2008 Mr. Steve H. Kanzer, CPA, Esq. Chief Executive Officer Pipex Pharmaceuticals, Inc. 3930 Varsity Drive Ann Arbor, MI 48108 Re: Pipex Pharmaceuticals, Inc. Preliminary Proxy Statement on Schedule 14A Filed on April 18, 2008 File Number 001-12584 Dear Mr. Kanzar:

We have completed our review of your proxy statement and have no further comments at this time. Please contact Sonia Barros at (202) 551-3655 with any questions. S i n c e r e l y , J e f f r e y R i e d l e r A s s i s t a n t D i r e c t o r cc: Steven Pappas, Esq. Lehman & Eilen LLP

Show Raw Text

Mail Stop 6010          April 29, 2008  Mr. Steve H. Kanzer, CPA, Esq. Chief Executive Officer Pipex Pharmaceuticals, Inc. 3930 Varsity Drive Ann Arbor, MI 48108
Re: Pipex Pharmaceuticals, Inc.
  Preliminary Proxy Statement on Schedule 14A
  Filed on April 18, 2008   File Number 001-12584
Dear Mr. Kanzar:

We have completed our review of your proxy statement and have no further comments at
this time.  Please contact Sonia Barros at (202) 551-3655 with any questions.         S i n c e r e l y ,            J e f f r e y  R i e d l e r         A s s i s t a n t  D i r e c t o r   cc: Steven Pappas, Esq.
Lehman & Eilen LLP

SecProbe.io